http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer. http://medicalxpress.com/news/2013-02-compound-high-kidney-cancer.html Cancer Tue, 19 Feb 2013 16:16:17 EST news280512956 (HealthDay)—Compared with final pathology, biopsy of small renal masses (SRMs) can be accurately used in a treatment algorithm to direct management, according to research published in the February issue of The Journal of Urology. http://medicalxpress.com/news/2013-02-biopsy-based-algorithm-accurate-small-renal.html Diseases, Conditions, Syndromes Sat, 09 Feb 2013 07:20:01 EST news279613252 (HealthDay)—A Hematuria Risk Index could identify cancer risk among patients with asymptomatic microscopic hematuria, according to a study published online Jan. 11 in the Mayo Clinic Proceedings. http://medicalxpress.com/news/2013-01-hematuria-index-ids-patients-cancer.html Cancer Mon, 14 Jan 2013 13:30:01 EST news277390560 The presence of microscopic hematuria – blood found in urine that can't be seen by the naked eye – does not necessarily indicate the presence of cancer, according to a Kaiser Permanente Southern California study published in the journal Mayo Clinic Proceedings. The study suggests that tests routinely done on patients with this condition could be avoided and has led to the creation of a screening tool to better diagnose certain types of cancers. http://medicalxpress.com/news/2013-01-routine-patients-microscopic-blood-urine.html Cancer Wed, 09 Jan 2013 12:00:05 EST news276953774 A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine. The two drugs together resulted in greater anti-cancer activity in ATC than either drug alone, says lead researcher Keith Bible, M.D., Ph.D., a Mayo Clinic oncologist. http://medicalxpress.com/news/2013-01-two-drug-combination-deadly-thyroid-cancer.html Cancer Tue, 08 Jan 2013 16:42:32 EST news276885650 (Medical Xpress)—Associate Professor Joe W. Ramos, PhD, a cancer biologist at the University of Hawai'i Cancer Center in collaboration with Assistant Professor William Chain, PhD, from the UH Mānoa's Chemistry Department are the first to describe the biological effects that a compound known as englerin A has on renal cancer cells.   Englerin A is a natural product found in the bark of phyllanthus engleri, a plant indigenous to east Africa. This compound was previously reported to be a potent and selective inhibitor that prevents the growth of six human renal cancer cell lines while not affecting other cancer cell types. Chain closely examined the chemical structure of englerin A and was able to effectively synthesize the compound in his lab.  http://medicalxpress.com/news/2012-11-renal-cancer-cells-bark-derived-drug.html Cancer Mon, 05 Nov 2012 08:10:01 EST news271324060 A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. http://medicalxpress.com/news/2012-10-stereotactic-radiosurgery-kidney-cancer.html Cancer Wed, 31 Oct 2012 17:35:56 EST news270923750 One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. http://medicalxpress.com/news/2012-10-replicating-genes-bipolar-disorder.html Psychology & Psychiatry Mon, 15 Oct 2012 10:54:04 EST news269517237 Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone in on the disease, called clear cell renal carcinoma, and kill the cancer by delivering radiation directly to it. However, the study shows that its effectiveness could be diminished when used after another anti-cancer therapy. http://medicalxpress.com/news/2012-06-molecular-imaging-treatment-protocol-kidney.html Cancer Mon, 11 Jun 2012 13:40:03 EST news258639754 (Medical Xpress) -- Swiss researchers have devised a method to detect mutations in tumor cells that are only present in a proportion of the cancer’s cells. The analysis reveals that cells of individual tumours are more variable than first thought – and differ from patient to patient. http://medicalxpress.com/news/2012-05-tumour-cells-individually.html Cancer Wed, 16 May 2012 09:36:43 EST news256379795